These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 6117611

  • 1. A simple method to determine the ratio of cardiac to vascular beta-receptor blockade in the rat in vivo.
    Kudo Y, Sokabe H, Zehr JE.
    J Pharmacobiodyn; 1981 Jul; 4(7):475-82. PubMed ID: 6117611
    [Abstract] [Full Text] [Related]

  • 2. The ratio of cardiac to vascular beta-receptor blockade of atenolol and propranolol in spontaneously hypertensive rats in vivo.
    Kudo Y, Sokabe H.
    J Pharmacobiodyn; 1982 Sep; 5(9):745-7. PubMed ID: 6296350
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cardiovascular effects of beta-adrenoreceptor blocking agents after intracerebroventricular administration in conscious normotensive cats.
    Day MD, Roach AG.
    Clin Exp Pharmacol Physiol; 1974 Sep; 1(4):333-9. PubMed ID: 4156505
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    Bowden CR, Marchione CS.
    J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
    [Abstract] [Full Text] [Related]

  • 7. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV.
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
    Riddell JG, Shanks RG.
    Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
    [Abstract] [Full Text] [Related]

  • 10. Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.
    Lee RJ, Dickerson DD, Fulmor IE, Goldberg ME.
    Proc Soc Exp Biol Med; 1978 Jun; 158(2):147-50. PubMed ID: 27818
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats.
    Day MD, Roach AG.
    Clin Sci Mol Med Suppl; 1975 Jun; 2():269s-272s. PubMed ID: 28878
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhancement of physiological finger tremor by intravenous isoprenaline infusions in man: evaluation of its role in the assessment of beta-adrenoceptor antagonists.
    Arnold JM, McDevitt DG.
    Br J Clin Pharmacol; 1984 Aug; 18(2):145-52. PubMed ID: 6148957
    [Abstract] [Full Text] [Related]

  • 20. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
    Beaulieu G, Grimes D, Muirhead C, Oshiro G.
    Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.